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ABSTRACT  
Aim: The main aim of this article is to prepare and evaluate sodium alginate microparticles and evaluate on the basis of their characterization. 
The drug is dissolved, encapsulated or attached to a microparticles matrix. Depending upon method of preparation microparticles were 
obtained. Microparticles were developed as a carrier for vaccines and other disease like rheumatoid arthritis, cancer etc. Microparticles were 
developed to increase the efficacy of active pharmaceutical ingredient to a specific targeted site. 
Material and Method: Microparticles of Sodium Alginate, Pepsin and Calcium Chloride were prepared in six batches (A-F) with different ratio 
of sodium alginate and calcium chloride respectively i.e. (0.25:2.5), (0.25:5), (0.25:7.5), (0.5:2.5), (0.5:5),  (0.5:7.5) by using a homogenizing 
method. Microparticles were evaluated for particle size distribution, zeta potential and morphology.  
Result and Discussion:  The normal particle size of each of the six batches were analyzed by Zeta Sizer (Delsa C Particle Analyzer) and it was 
found that the Batch B (0.25:5) delivered the best microparticles with size distribution of 1.2731 (µm). All batches were see n under Motic 
magnifying microscope by using the Sulforhodamine B (M.W. 479.02) color as staining dye. Microparticles was found to be semi spherical in 
shape. 
Conclusion: Results of all the six batches was contrasted based on particle size investigation, zeta potential and morphology. Batch B (0.25:5) 
was considered as the best formulation. 
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INTRODUCTION 
Microparticles are defined as a solid dispersion with a size 
range between 1 to 1000 μm in diameter[1]. Microparticles 
can be directly injected into the target tissues without 
damaging the specific tissue. Blood Brain Barrier (BBB) 
protects the central nervous system against toxins and 
makes it difficult for a drug to reach the brain to treat certain 
disease[2]. Microparticles help in minimize the toxic effect 
and loss of drug in non-targeted sites. Drug-loaded 
biodegradable microparticles can be directly injected into 
the brain tissue to improve the efficiency of drug to treat 
certain disease[3]. Microparticles have a high surface area 
for a drug to release and have a short diffusion pathway that 
helps to increase the therapeutic efficacy and reduces the 
side effects[4]. Biodegradable polymeric microparticles are 
coated with a hydrophilic polymer such as polyethylene 
glycol (PEG) which are used in a drug delivery device 
because of their ability to bind with a particular organ for a 
prolonged period of time[5]. PEG act as a carrier of DNA in a 
gene therapy and their ability to deliver proteins, peptides 
and genes to a particular part of a human body[6]. When 
microparticles are administered in the form of drug into the 
stomach or GIT tract then drug get absorbed into the blood 
and distributed throughout the system. When the drug is 
absorbed into the blood then there is no uniform delivery of 
drug to a target site which results in decrease in 
concentration[7]. To avoid low concentration of drug in the 
blood, controlled or sustained drug delivery system is 
preferred which helps the drug to incorporate within a 
polymeric matrix that controls the release rate and results in 
constant drug concentration at site of action for a prolonged 
period of time[8]. 
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Advantages 
1) Microparticles helps in enhancing solubility of poorly 
water-soluble drugs. 
2) They possess immediate release properties and can give 
80% or more of the drug in less time. 
3) They help in targeted release of active pharmaceutical 
ingredient and prolong the drug release. 
4) They help in increasing the bioavailability of drugs. 
5) They help in minimize or eliminate side effects. 
6) They help in reducing the dose size and dosing frequency 
which help to maintain the plasma concentration and 
improve patience compliance. 
7) Size optimization and use of various targeting ligands can 
be conjugated with a drug to achieve a controlled/sustained 
release of drug to a specific targeted site. 
8) They can act as a carrier for drugs and vaccines in 
diagnostic and surgical procedures. 
9) Microparticles can be used for various routes of 
administration like oral, nasal, parentral, intraocular etc. 
10) There will be a less chances of dose dumping and ensure 
better compatibility. 
Limitation 
1) Small particle size and large surface area result in limited 
drug loading and particle aggregation. 
2) Microparticles have less reproducibility. 
3) Different process like change in temperature, pH and 
solvent addition helps in achieving the stability of core 
particles.  
Pepsin is produced in the stomach and is one of the main 
digestive enzymes where it digests the proteins in food 
inside the digestive system in humans. Pepsin is most active 
in acidic medium between 37ºC and 42ºC. Pepsin show 
maximum activity at PH-2 and minimum activity at PH-
6.5[9]. Sodium Alginate (ALG) is a hydrophilic polymer 
which is obtained from seaweeds. ALG is a biocompatible, 
non-irritant polymer which has swelling, gelling, 
mucoadhesive and stabilizing properties[10]. Sodium 
Alginate is also used as thickening agent in food industry. 
Cross linking of ALG with calcium chloride decrease the 
swelling ratio and enhance mucoadhesive property of the 
drug[11]. This is a prominent approach of obtaining 
microparticles and modified release in drug delivery system. 
Sodium Alginate is able to form a gel when dissolved in 
water in the presence of a divalent cation (Ca2+ions) when 
cross linked with calcium chloride or exposed to certain 
salts[12]. This cross-linking reaction between sodium 
alginate and calcium chloride forms a spherical or semi 
spherical beads. Pepsin is also obtained from the gastric 
mucosa of pigs, cattle and sheep. So, binding of pepsin with 
sodium alginate will helps in enhancing the mucoadhesive 
property in gastric mucosa[13]. 
2. MATERIALS AND METHODS  
The analytical grade of each substance was used in these 
experiments. Sodium Alginate (Algin, a cream-colored pale 
yellowish-brown powder, soluble in water forming a viscous 
colloidal solution, LOD-15.0% at 105ºC for 4 hrs.) and pepsin 
(from the porcine stomach, 1:3000) were purchased from 
central drug house (p) LTD. New Delhi-110002.Calcium 
chloride (CaCl2  2H2O, M.W-147.02) was supplied from Loba 
Chemie Pvt. Ltd. Wodehouse Road, Mumbai, 400005, India. 
1. Method of Preparation  
Sodium Alginate solution was prepared in different 
concentration i.e. 0.25% and 0.5%. Sodium Alginate solution 
was prepared by dissolving sodium alginate in distilled 
water and solution was stirred continuously with slightly 
heating at 55ºC- 60ºC to dissolve sodium alginate in water. 
After cooling the sodium alginate solution, 0.6 mg of pepsin 
was added and the drug loaded sodium alginate was 
prepared. The calcium chloride solution was also prepared in 
different concentrations. i.e. 2.5%, 5%, 7.5%. The drug 
loaded sodium alginate solution was dropwise added into 
the calcium chloride solution by putting the calcium chloride 
solution in a magnetic stirrer (made by Remi equipment) and 
stirred at 1000 rpm. By adding different concentrations 
solution of sodium alginate with different concentrations of 
calcium chloride solution, a total of 6 different formulations 
were developed. After that, all the 6 solutions were 
homogenized by a homogenizer mixer made by Remi motor 
at 1250 rpm. Then micron size of sodium alginate 
microparticles were formed by continuous stirring for 15-20 
minutes. The size of particles of 6 different solutions was 
evaluated by using dynamic light scattering zeta sizer (made 
by Delsa nano C particle Analyzer). Zeta potential can also be 
checked for different samples by using the same dynamic 
light scattering zeta sizer. (Figure 1& 2). 
 
 
 
Figure 1 Diagrammatic representation of experiment 
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Figure 2: Dropwise addition of Sodium Alginate into Calcium Chloride Solution using Magnetic Stirring 
 
2. Evaluation of Microparticles 
2.1. Standard Curve of Pepsin 
To get concentration of 0.6 mg, dilution was made from stock 
solution of Pepsin (100µg/ml). Absorbance of Pepsin at 
275 nm was taken in UV/Visible Spectrometer. The 
calibration curve was plotted between Absorbance 
verses Concentration. (Figure 3). 
 
Figure 3: Standard Curve of Pepsin 
2.2. Determination of Drug Content 
For determination of drug content, 10 mg of beads were 
placed in 100 ml of distilled water for 24 hours. The solution 
was than filtered and measured for the drug content using 
UV Spectrophotometer. Drug content was calculated using a 
standard calibrated curve. The drug loading capacity was 
calculated using a following equation: 
Drug Loading (%) = 
                                
                        
 x 100 
Drug loading can be done at the time of microparticles 
production by incubating the carrier with a concentrated 
drug solution. 
2.3. Scanning Electron Microscopy (SEM) 
Scanning electron microscopy is a type of electron 
microscope that scan the surfaces with a focused beam of 
electrons to produce images. SEM was mainly used to 
examine the morphology of the sample. The sample is 
prepared by mounting the beads on the stub. The stub was 
coated either with gold or carbon. The gel beads were then 
observed under a scanning electron microscope.   
2.4. Particle Size Distribution 
Particle size determination was carried out using an optical 
microscope. A suspension of sodium alginate beads 
containing pepsin was prepared in a beaker. A droplet of 
pepsin loaded sodium alginate microparticles were 
suspended on a glass slide. A cover slip was gently placed on 
the sample. While placing the cover slip, no bubbles should 
be entrapped inside the cover slip. The average diameter of 
beads was calculated by following equation 
X= 
     
 
 
X= Average Particle Diameter,  
Xi= Individual diameter of beads 
N= Number of Beads 
2.5. Particle Size and Zeta Potential Analysis 
Measurement of particle size and Zeta Potential was done by 
Dynamic Light Scattering (Delsa Nano C particle 
Analyzer)[14]. For particle size measurement, size cell or 
disposable rectangular cell was used whereas for Zeta 
Potential measurement, flow cell or high concentration cell 
was used. The lyophilized microparticles were placed in a 
standard glass cuvette. The glass cuvette was slowly filled 
with homogenized sample by syringe. No bubbles should be 
entrapped inside the cuvette. After opening the lid sample 
was placed and analyzed. 
2.6 Morphology  
2.6.1 Microscopy Observation and Particle Size 
Morphology of pepsin loaded sodium alginate microparticles 
were determined by using Motic Microscope. A droplet of 
pepsin loaded sodium alginate microparticles were 
suspended on a glass slide (3’’x 1’’x 1 mm). Samples were 
stained with a Sulforhodamine B solution (prepared by using 
0.5% solution of acetic acid and distilled water). A cover slip 
was gently placed on the sample. While placing the cover 
slip, no bubbles should be entrapped inside the cover slip. 
Sample placed on a glass slide was observed under 
microscope with a magnification of 40x.Under microscope it 
y = 0.0002x + 0.0517 
R² = 0.9958 
0
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was assumed that particle size was found to be semi 
spherical in shape.  
2.7 Entrapment Efficiency 
Drug Entrapment Efficiency refers to a load of drug (pepsin) 
into a carrier (alginate microparticles). This entrapment 
efficiency was determined by using UV Spectroscopy Method. 
For this, 10 ml of pepsin loaded alginate microparticles was 
loaded into Centrifugation tube at 1000 rpm for 10 min. 
Supernatant was analyzed by using UV/ Visible 
Spectrophotometer at 275 nm. Drug concentration was 
determined using standard calibration curve. 
Entrapment Efficiency was calculated using formul 
   Entrapment Efficiency (EE) % = 
     
  
 X 100  
Where,  
              Ct is Concentration of Total Drug  
              Cf is Concentration of Entrapped Drug 
2.8 In-vitro Drug Release Studies 
In-vitro drug release studies were performed by using USP 
Dissolution Type II apparatus (Paddle Type). The drug 
release studies were carried out by adding 900 ml of 
phosphate buffer solution (7.4 PH) into vessel and 
temperature was maintained at 37ºC ± 0.5ºC. The speed of 
stirrer was maintained at 50 rpm. Accurately weighed 
samples of sodium alginate beads were added into the 
vessels. 5 ml of solution was withdrawn and 5 ml of solution 
was added into the vessel after predetermined time interval 
(30 minutes) to maintain sink condition. The sample 
withdrawn is then filtered by Whatman filter paper and 
absorbance was analyzed using UV Spectrophotometer at 
275 nm. The experiment was performed in triplicate      
3. RESULT AND DISCUSSION: 
Microparticles were prepared by modified emulsification 
method. Sodium Alginate which is an anionic polysaccharide, 
drug is loaded into it. Sodium Alginate was dropped into 
calcium chloride solution with constant stirring through 
syringe. Monovalent sodium ion show reaction with divalent 
calcium ion, it replaces the sodium with calcium ions which 
results in the formation of calcium alginate microparticles. 
3.1 Standard Curve of Pepsin 
The calibration curve was plotted between absorbance 
verses concentration. 
3.2 Morphology Study 
The microparticles were observed under a Motic Microscope 
and the particle were observed semi spherical in shape. The 
images taken from the microscope are shown in Figure 4. 
3.3 Size Distribution Studies 
The size distribution studies was done using dynamic light 
scattering technology (Zeta Sizer). The size of the 
microparticles varies from Batch A to F. Lowest value was 
observed in Batch B i.e. 1273.1μm and Highest value was 
observed in Batch F i.e. 91.4 μm. (Figure 5) 
3.4 Zeta Potential Studies 
Zeta Potential of pepsin containing microparticles was 
determined by using Zeta Sizer. Zeta Potential was measured 
for few batches and values varies from -2.61 (Batch A) to 
3.13 (Batch C) (Figure 6). 
 
   
   
Figure 4 Morphological Studies of Microparticles containing Pepsin using motic microscope (A) Morphology of Pepsin 
containing Microparticles at (0.25 :2.5)  ratio of Sodium Alginate :Calcium Chloride (B)Morphology of Pepsin 
containing Microparticles at (0.25:5) ratio of Sodium Alginate :Calcium Chloride (C) Morphology of Pepsin containing 
Microparticles at (0.25:7.5) ratio of Sodium Alginate: Calcium Chloride (D)Morphology of Pepsin containing 
Microparticles at (0.5:2.5) ratio of Sodium Alginate: Calcium Chloride(E) Morphology of Pepsin containing  
Microparticles at (0.5:5) ratio of Sodium Alginate: Calcium Chloride (F) Morphology of Pepsin containing 
Microparticles at (0.5:7.5)ratio of Sodium Alginate: Calcium Chloride 
A B C 
D E F 
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Figure5: Particle Size Analysis using Dynamic Light Scattering (A) Particle Size of    Pepsin containing Microparticles at 
0.25:2.5 ratio Sodium Alginate: Calcium Chloride      (B) Particle Size of Pepsin containing Microparticles at 0.25:5 ratio 
Sodium Alginate: Calcium Chloride (C) Particle Size of Pepsin containing Microparticles at 0.25:7.5 ratio Sodium 
Alginate: Calcium Chloride (D) Particle Size of Pepsin containing Microparticles at  0.5:2.5 ratio Sodium Alginate: 
Calcium Chloride (E) Particle Size of Pepsin containing Microparticles at 0.5:5 ratio Sodium Alginate: Calcium Chloride 
(F) Particle Size of Pepsin containing Microparticles at 0.5:7.5 ratio Sodium Alginate: Calcium Chloride 
 
 
 
A 
 
C 
C 
D 
B A 
E F 
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Figure 6:Zeta Potential is calculated by using Zeta Sizer (A) Zeta Potential of Pepsin containing Microparticles at 
0.25:2.5 ratio of Sodium Alginate: Calcium Chloride (B) Zeta Potential  of Pepsin containing Microparticles at 0.25:5 
ratio of Sodium Alginate: Calcium Chloride (C) Zeta Potential of Pepsin containing Microparticles at 0.25:7.5 ratio of 
Sodium Alginate: Calcium Chloride (D) Zeta Potential of Pepsin containing Microparticles at 0.5:2.5 ratio of Sodium 
Alginate: Calcium Chloride (E) Zeta Potential of Pepsin containing Microparticles at 0.5:5 ratio of Sodium Alginate: 
Calcium Chloride (F) Zeta Potential of Pepsin containing Microparticles at 0.5:7.5 ratio of Sodium Alginate: Calcium 
Chloride 
 
4. CONCLUSION: 
The sodium alginate microparticles (polymer) were 
prepared at different ratio 0.25:0.5 and calcium chloride 
(crosslinking agent) was prepared at ratio 2.5:5:7.5. These 
formulations were loaded with pepsin. Different test was 
evaluated at 6 different concentrations. 
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